Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives
Anaphylaxis is a type I hypersensitivity reaction that is potentially fatal if not promptly treated. It is a clinical diagnosis, although measurement of serial serum total mast cell tryptase (MCT) is gold standard and may help differentiate anaphylaxis from its mimics. The performance characteristic...
Main Authors: | Sarah C. Beck, Thomas Wilding, Richard J. Buka, Richard L. Baretto, Aarnoud P. Huissoon, Mamidipudi T. Krishna |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00494/full |
Similar Items
-
Peri-Operative Anaphylaxis—An Investigational Challenge
by: Siraj A. Misbah, et al.
Published: (2019-05-01) -
Editorial: Anaphylaxis – A Distinct Immunological Syndrome, but How Much Do We Really Understand?
by: Mamidipudi Thirumala Krishna, et al.
Published: (2019-12-01) -
Biomarkers of anaphylaxis
by: N. V. Esakova, et al.
Published: (2022-09-01) -
State-of-the-Art on Biomarkers for Anaphylaxis in Obstetrics
by: Anca Angela Simionescu, et al.
Published: (2021-08-01) -
Improving Diagnostic Accuracy of Anaphylaxis in the Acute Care Setting
by: Bjornsson, Hjalti M, et al.
Published: (2010-12-01)